EARLY SERUM HEPATITIS B VIRUS LARGE SURFACE PROTEIN LEVEL: A STRONG PREDICTOR OF VIROLOGICAL RESPONSE FOR PEGINTERFERON, BUT NOT FOR ENTECAVIR, IN HBeAg-POSITIVE CHRONIC HEPATITIS B

被引：0
作者：
Zhu, X. J. [1 ]
Gong, Q. M. [1 ]
Yu, D. M. [1 ]
Zhang, D. H. [1 ]
Gu, L. L. [1 ]
Han, Y. [1 ]
Chen, J. [1 ]
Zhang, X. X. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Dept Infect Dis, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60785-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
783
引用
收藏
页码：S319 / S319
页数：1
相关论文
共 50 条
[41]   COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A VERSUS ENTECAVIR IN THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA [J].
Sheng, F. .
VALUE IN HEALTH, 2009, 12 (07) :A428-A429
[42]   Correlation of Serum Hepatitis B Surface Antigen Level With Response to Entecavir in Naive Patients With Chronic Hepatitis B [J].
Lee, Myoung Hee ;
Lee, Da Mi ;
Kim, Soon Sun ;
Cheong, Jae Youn ;
Cho, Sung Won .
JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (07) :1178-1186
[43]   Baseline serum hepatitis B core antibody level predicts HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B after antiviral treatment [J].
Zhao, Xiang-An ;
Wang, Jian ;
Liu, Jiacheng ;
Chen, Guangmei ;
Yan, Xiaomin ;
Jia, Bei ;
Yang, Yue ;
Liu, Yong ;
Gu, Da ;
Zhang, Zhaoping ;
Xiang, Xiaoxing ;
Huang, Rui ;
Wu, Chao .
ANTIVIRAL RESEARCH, 2021, 193
[44]   On-treatment HBV DNA dynamics predict virological breakthrough in entecavir-treated HBeAg-positive chronic hepatitis B [J].
Huang, Yi-Jie ;
Chang, Chi-Sen ;
Peng, Yen-Chun ;
Yeh, Hong-Zen ;
Yang, Sheng-Shun .
PLOS ONE, 2017, 12 (03)
[45]   Serum Alpha-Fetoprotein as a Predictor of Liver Fibrosis in HBeAg-Positive Chronic Hepatitis B Patients [J].
Yang, Kai ;
Pan, Ying ;
Liu, Liwei ;
Sun, Beibei ;
Shi, Wei .
MEDICINA-LITHUANIA, 2023, 59 (05)
[46]   Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic Hepatitis [J].
Zhang, Zhan-qing ;
Wang, Yan-bing ;
Lu, Wei ;
Liu, Dan-ping ;
Shi, Bi-sheng ;
Zhang, Xiao-nan ;
Huang, Dan ;
Li, Xiu-fen ;
Zhou, Xin-lan ;
Ding, Rong-rong .
ANNALS OF LABORATORY MEDICINE, 2019, 39 (01) :67-75
[47]   Addition of (pegylated) interferon to entecavir increases response in treatment naive HBeAg-positive patients with chronic hepatitis B [J].
Liem, S. ;
van Campenhout, M. J. ;
Chi, H. ;
Brouwer, W. P. ;
Xie, Q. ;
Qi, X. ;
Liang, C. ;
Tabak, F. ;
Hansen, B. E. ;
Janssen, H. L. .
JOURNAL OF HEPATOLOGY, 2017, 66 (01) :S692-S692
[48]   Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B [J].
Li, Minghui ;
Gao, Yuanjiao ;
Yang, Liu ;
Lin, Yanjie ;
Deng, Wen ;
Jiang, Tingting ;
Bi, Xiaoyue ;
Lu, Yao ;
Zhang, Lu ;
Shen, Ge ;
Liu, Ruyu ;
Wu, Shuling ;
Chang, Min ;
Xu, Mengjiao ;
Hu, Leiping ;
Song, Rui ;
Jiang, Yuyong ;
Yi, Wei ;
Xie, Yao .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[49]   Decline in Quantitative Serum HBsAg Level during Consolidation Therapy Following HBeAg Loss in HBeAg-positive Chronic Hepatitis B Patients Treated with Entecavir [J].
Su, Wen-Pang ;
Peng, Cheng-Yuan ;
Lai, Hsueh-Chou ;
Lin, Chia-Hsin ;
Chuang, Po-Heng ;
Chen, Sheng-Hung .
HEPATOLOGY, 2014, 60 :1102A-1103A
[50]   Virological response to antiviral therapy at week 12 indicates a great reduction of intrahepatic hepatitis B virus DNA and cccDNA in HBeAg-positive chronic hepatitis B patients [J].
Lu, H. Y. ;
Zhuang, L. W. ;
Yu, Y. Y. ;
Si, C. W. .
JOURNAL OF VIRAL HEPATITIS, 2010, 17 :59-65
12345